06/15/2026
A powerful reminder that innovation in healthcare isn't always about entirely new drugs—it's often about rethinking how we use what we already have.
A new study out of Toronto's Baycrest is shedding light on *paratonia*—a little-known but common symptom of advanced dementia that causes painful, involuntary muscle stiffness and is often misunderstood as resistance or aggression.
What's encouraging: researchers are seeing promising results using botulinum toxin (Botox), a treatment already widely used for other neurological conditions, to ease stiffness, reduce pain, and improve quality of life for both patients and caregivers.
While still experimental and not yet widely accessible, the implications are significant—especially as the number of Canadians living with dementia continues to rise.
A compelling look at how awareness + repurposed therapies could meaningfully change dementia care.
globalnews.ca